Latest Articles
GLP 1 Receptor Agonists Reduce Endometrial Cancer Risk - European Medical Journal
GLP 1 Receptor Agonists Reduce Endometrial Cancer Risk European Medical Journal
Published: Feb. 18, 2026, noon
GLP 1 Receptor Agonists Reduce Endometrial Cancer Risk - EMJ | Elevating the quality of healthcare globally
GLP 1 Receptor Agonists Reduce Endometrial Cancer Risk EMJ | Elevating the quality of healthcare globally
Published: Feb. 18, 2026, noon
A 60-Year-Old Woman With Endometrial Intraepithelial Neoplasia: A Case of Persistent Postmenopausal Bleeding - Cureus
A 60-Year-Old Woman With Endometrial Intraepithelial Neoplasia: A Case of Persistent Postmenopausal Bleeding Cureus
Published: Feb. 18, 2026, 2:58 a.m.
Adding GLP-1RA to Progestin Therapy may reduce Endometrial Cancer Risk among women with benign uterine... - Medical Dialogues
Adding GLP-1RA to Progestin Therapy may reduce Endometrial Cancer Risk among women with benign uterine... Medical Dialogues
Published: Feb. 17, 2026, 3:15 p.m.
Glucagon-like peptide-1 receptor agonists may reduce endometrial cancer risk in endometrial hyperplasia - 2 Minute Medicine
Glucagon-like peptide-1 receptor agonists may reduce endometrial cancer risk in endometrial hyperplasia 2 Minute Medicine
Published: Feb. 17, 2026, 12:15 a.m.
Comedian Fatiha El-Ghorri, 44, has been through a hysterectomy after being diagnosed with endometrial cancer - UrbanMatter
Comedian Fatiha El-Ghorri, 44, has been through a hysterectomy after being diagnosed with endometrial cancer UrbanMatter
Published: Feb. 16, 2026, 9:11 p.m.
Comedian Fatiha El-Ghorri, 44, reveals she has undergone a hysterectomy after being diagnosed with endometrial cancer - Daily Mail
Comedian Fatiha El-Ghorri, 44, reveals she has undergone a hysterectomy after being diagnosed with endometrial cancer Daily Mail
Published: Feb. 16, 2026, 1:01 p.m.
Comedian Fatiha El-Ghorri, 44, reveals she has undergone a hysterectomy after being diagnosed with endometrial cancer - dailymail.co.uk
Comedian Fatiha El-Ghorri, 44, reveals she has undergone a hysterectomy after being diagnosed with endometrial cancer dailymail.co.uk
Published: Feb. 16, 2026, 1:01 p.m.
Eli Lilly Builds $1.5 Billion Stockpile of Oral GLP-1 Drug as Study Shows 66% Drop in Endometrial Cancer Risk for Certain Patients - geneonline.com
Eli Lilly Builds $1.5 Billion Stockpile of Oral GLP-1 Drug as Study Shows 66% Drop in Endometrial Cancer Risk for Certain Patients geneonline.com
Published: Feb. 16, 2026, 10:55 a.m.
Study Finds GLP-1 Medications Combined with Progestin Therapy May Lower Endometrial Cancer Risk - geneonline.com
Study Finds GLP-1 Medications Combined with Progestin Therapy May Lower Endometrial Cancer Risk geneonline.com
Published: Feb. 16, 2026, 6:10 a.m.
Link copied to clipboard!